Dyadic International to Present at Advanced Biofuels Leadership Conference
Wednesday, April 20, 2011 at 2:00 p.m. ET, Capital Hilton, Washington, D.C.
JUPITER, Fla., April 11, 2011 -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced that its President and Chief Executive Officer, Mark Emalfarb, will present at the Advanced Biofuels Leadership Conference taking place from April 19-21, 2011 at the Capital Hilton in Washington, D.C., on Wednesday, April 20, 2011 at 2:00 p.m. ET. Following the live presentation, a slide presentation will be available on Dyadic's website at www.dyadic.com.
The Advanced Biofuels Leadership Conference brings together the leaders guiding the development of advanced biofuels as well as emerging feedstocks. The conference focuses on the key drivers for biofuels commercialization including processing technologies, finance, policy, and feedstocks from those in a unique position to make decisions.
About Dyadic
Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries.
SOURCE Dyadic International, Inc.
CONTACT: Dyadic International, Inc., Adam J. Morgan, Vice President General Counsel & Business Development, +1-561-743-8333, amorgan@dyadic.com
Web Site: www.dyadic.com
